Isabl

Cancer tests based on whole genome and transcriptome data.

Y CombinatorWinter 2020ActiveHealthcareDiagnosticsBiotechDiagnostics

What they do

Problem

Cancer patients often receive tumor genetic tests that assess only a limited set of mutations, missing actionable insights from the full genomic landscape.

Solution

Software that analyzes whole-genome and transcriptome sequencing data from tumors to identify mutations and clarify tumor biology for clinical decision-making and biomarker discovery.

Who it's for

Clinical laboratories, hospitals, and oncology researchers who sequence tumors and need comprehensive genomic interpretation.